Cancer Articles, News & Research Info | Treatment & Drug Trials


Hormone Receptor Levels Predict Trastuzumab Effect

Patients with human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer whose tumors also express hormone receptors may be less responsive to the addition of trastuzumab to chemotherapy, suggesting that hormone-receptor expression has a predictive role in determining response to therapy.

Next post in Bone Cancer Clinical Trials